Innoviva (INVA) EPS (Basic) (2010 - 2026)

Innoviva's (INVA) quarterly EPS (Basic) came in at $2.52 in Q1 2026, up 438.67% YoY from $0.47 in Q1 2025, and up 1092.12% on a QoQ basis from -$0.25 in Q4 2025.

Innoviva (INVA) EPS (Basic) (2010 - 2026) Analysis & Trends

Innoviva (INVA) has 17 years of EPS (Basic) data on file, last reported at $2.52 in Q1 2026.

  • Quarterly EPS (Basic) rose 438.67% year-over-year to $2.52 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.59 (up 204.1% YoY) and the FY2025 annual result came in at $4.85, up 1200.52% from the prior year.
  • EPS (Basic) improved to $2.52 in Q1 2026, from -$0.25 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $4.05 in Q3 2022 to a low of -$3.16 in Q4 2024.
  • A 5-year average of $0.43 and a median of $0.05 in 2024 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2024 — EPS (Basic) plunged 2931.76% — and 2025, when it soared 3034.11%.
  • Tracing INVA's EPS (Basic) over 5 years: stood at -$0.23 in 2022, then jumped by 31.88% to -$0.16 in 2023, then tumbled by 1931.17% to -$3.16 in 2024, then jumped by 91.97% to -$0.25 in 2025, then jumped by 1092.12% to $2.52 in 2026.
  • The last three EPS (Basic) figures came in at $2.52 (Q1 2026), -$0.25 (Q4 2025), and $1.55 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Innoviva 1.54 Bn 968.79 Mn 90.62 Mn -1.14

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.14
Mar 31, 2026 2.52
Dec 31, 2025 -0.25
Sep 30, 2025 1.55
Jun 30, 2025 1.01
Mar 31, 2025 -0.74
Dec 31, 2024 -3.16
Sep 30, 2024 0.05
Jun 30, 2024 -0.55
Mar 31, 2024 0.58
Dec 31, 2023 -0.16
Sep 30, 2023 1.82
Jun 30, 2023 0.02
Mar 31, 2023 0.51
Dec 31, 2022 -0.23
Sep 30, 2022 4.05
Jun 30, 2022 0.01
Mar 31, 2022 0.23
Dec 31, 2021 -0.55
Sep 30, 2021 3.68